Roche Canada expands global informatics hub in Ontario
Invest Ontario is supporting Roche Canada’s more than $130M investment to create up to 250 jobs in AI, machine learning, computational biology and data analytics.
Image
Explore the strategic advantages of Ontario as the ideal location for Contract Development Manufacturing Organizations (CDMOs) and pharmaceutical companies. With a rich heritage of manufacturing excellence and access to top talent and world-class research partners, Ontario empowers you to develop and produce groundbreaking molecules at scale. Foster the future of pharmaceutical manufacturing right here in Ontario, where your ambitions can thrive.
Image
Image
Leverage Ontario's Strategic Location
Expand your CDMO business by partnering with a global clientele from Ontario. Benefit from access to top pharmaceutical companies and biotech startups and tap into major North American markets with 194+ million consumers within a day’s drive of the Greater Toronto Area. Take advantage of preferential access to global markets through 15 trade agreements for efficient distribution of your pharmaceutical products manufactured in Ontario.
Exceptional Talent and Ecosystem
Unlock Ontario's pharmaceutical potential by harnessing its robust life sciences ecosystem. Benefit from top-tier talent and R&D support from world-leading academic and research institutions. Ontario hosts world-renowned research centres, hospitals and clinics such as the Ontario Cancer Institute, SickKids, Mount Sinai and the London Health Sciences Centre offering invaluable resources in areas cancer research, regenerative medicine, diagnostic imaging, and neuroscience. Collaborate with CDMOs to accelerate drug development through strategic partnerships, ensuring efficient progress towards your goals.
OmniaBio Inc. will be a game-changer for Ontario and Canada. It will provide missing infrastructure to allow Ontario and Canadian cell and gene companies to remain here, while also attracting foreign companies. Cell and gene therapy is Canada’s opportunity to be global leaders in life sciences. Investing in manufacturing is a key driver, and we’re grateful to Invest Ontario for its leadership and foresight.
Michael May
Chair, OmniaBio Inc.
Omniabio: Road to Canada’s largest cell and gene therapy CDMO
With the support of Invest Ontario, OmniaBio has built a new biomanufacturing facility in Hamilton, Ontario with an overall project investment of over $580 million, creating 250 skilled jobs.
Ontario congratulates AstraZeneca on investment in Ontario to advance the fight against cancer and rare diseases
Discover Ontario’s growing life sciences sector with AstraZeneca’s announcement of investment in clinical trials bringing 500 new jobs in Peel and the surrounding region.
Unleashing Innovation and Collaboration: Ontario, Canada’s Life Sciences Sector Leads the Way
Senior Economic Officers Aaron Pinto and Chelsea Peet discuss Ontario’s key life sciences value propositions and what makes the province a leader in the sector.
Invest Ontario supports new biomanufacturing facility in Hamilton
Invest Ontario supports new biomanufacturing facility in Hamilton, Canada. Project with OmniaBio Inc. drives global leadership in cell and gene therapy.
Ontario attracts economic opportunities with Trade Mission to India
The Ontario government has concluded a successful trade mission to India to strengthen relationships with economic partners and attract new investments in key sectors.
Ontario promotes growing life sciences sector during Trade Mission to Boston
Invest Ontario was at BIO 2023 to promote the province’s growing life sciences and biotech sector and explore new opportunities for investment.